Julie Turpin
Known title: EVP/Chief People OfficerCIK: 0001861040
Associated companies
Transaction History
| BRO | ▲ Buy | Grant | 11,704 | $0 | 2/26/2026 | View on chart |
| BRO | ▲ Buy | Grant | 2,855 | $0 | 2/26/2026 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 4,418 | $307K | 2/23/2026 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 2,226 | $246K | 5/5/2025 | View on chart |
| BRO | ▲ Buy | Grant | 6,802 | $0 | 2/24/2025 | View on chart |
| BRO | ▲ Buy | Grant | 1,342 | $0 | 2/24/2025 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 1,392 | $155K | 2/21/2025 | View on chart |
| BRO | ▼ Sell | Open Market | 3,350 | $301K | 6/7/2024 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 2,071 | $174K | 2/25/2024 | View on chart |
| BRO | ▲ Buy | Grant | 1,814 | $0 | 2/19/2024 | View on chart |
| BRO | ▲ Buy | Grant | 8,120 | $0 | 2/19/2024 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 2,243 | $127K | 2/26/2023 | View on chart |
| BRO | ▲ Buy | Grant | 3,710 | $0 | 2/20/2023 | View on chart |
| BRO | ▲ Buy | Grant | 4,848 | $0 | 2/20/2023 | View on chart |
| BRO | ▲ Buy | Grant | 1,950 | $0 | 2/20/2023 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 2,378 | $153K | 2/24/2022 | View on chart |
| BRO | ▲ Buy | Grant | 6,098 | $0 | 2/21/2022 | View on chart |
| BRO | ▲ Buy | Grant | 1,133 | $0 | 2/21/2022 | View on chart |
| BRO | ▼ Sell | Tax Withholding | 2,720 | $175K | 1/21/2022 | View on chart |
| BRO | ▲ Buy | Grant | 14,228 | $0 | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Brown & Brown Faces Mixed Analyst Views on Valuation
Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.
Brown & Brown Faces Mixed Analyst Views on Valuation. Brown & Brown is seeing diverging opinions from Wall Street analysts. Wells Fargo lowered its price target to $68, citing concerns about core business weakness, while TD Cowen initiated coverage with a higher target of $82. The stock currently trades near a key support level, reflecting a market weighing these conflicting assessments of the company's value.